Clinical Trials Directory

Trials / Sponsors / Palobiofarma SL

Palobiofarma SL

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
CompletedTherapeutic Effect of PBF-680 in Patients With COPD
COPD
Phase 22021-12-20
CompletedStudy to Assess the Safety and Tolerability of PBF-1650 in Healthy Volunteers.
Psoriasis
Phase 12018-12-10
UnknownPBF-1129 in Patients With NSCLC
Locally Advanced or Metastatic NSCLC
Phase 12018-10-01
CompletedSafety and Efficacy of PBF-677 in Ulcerative Colitis Patients
Ulcerative Colitis
Phase 22018-07-01
CompletedStudy to Investigate the Effect of PBF-680 on Forced Expiratory Volume in 1 Second (FEV1) in Asthmatic Patient
Asthma
Phase 22018-06-01
CompletedStudy of PBF-999 in Solid Tumour Advanced Cancer
Cancer
Phase 12017-10-01
CompletedA Study to Assess the Efficacy of a 5-day, 10- mg PBF-680 Oral Administration on Late Asthmatic Responses (LAR
Asthma
Phase 22016-04-01
TerminatedStudy to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF-999 "After Multiple Oral Doses" in
Huntington Disease
Phase 12016-03-01
Completed"First-in-human" Study To Assess the Safety and Tolerability of PBF-677 in Healthy Volunteers
Glaucoma
Phase 12015-12-01
CompletedTrial of PBF-509 and PDR001 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer (NSCLC)
Phase 12015-10-01